Clinical Trials on Pulmonary Emphysema in New Zealand
Total 1022 results
-
Uptake Medical CorpCompletedEmphysemaAustralia, Ireland, Germany, Austria, New Zealand, United Kingdom
-
Grifols Therapeutics LLCEnrolling by invitationPulmonary Emphysema in Alpha-1 Antitrypsin DeficiencyUnited States, New Zealand, Denmark, Australia, Finland, Estonia, Canada, Poland, Russian Federation, Sweden, France
-
Arrowhead PharmaceuticalsCompleted
-
Dicerna Pharmaceuticals, Inc.WithdrawnAlpha 1-Antitrypsin DeficiencyNew Zealand
-
Kawut, Steven, MDPfizerCompletedPulmonary Disease, Chronic Obstructive | EmphysemaUnited States
-
Apreo Health, Inc.RecruitingEmphysema or COPDAustralia
-
Universität Duisburg-EssenRecruiting
-
Grifols Therapeutics LLCActive, not recruitingPulmonary Emphysema in Alpha-1 PI DeficiencyUnited States, Australia, Denmark, New Zealand, Estonia, Poland, Russian Federation, Sweden, Brazil, Canada, France, Finland
-
Weill Medical College of Cornell UniversityNational Heart, Lung, and Blood Institute (NHLBI)CompletedEmphysema | HIV | Chronic Obstructive Pulmonary Disease (COPD)United States
-
Columbia UniversityAlpha-1 Foundation; Stony Wold-Herbert Fund, Inc.CompletedChronic Obstructive Pulmonary Disease | Emphysema | Alpha-1 Antitrypsin DeficiencyUnited States
-
Columbia UniversityCompletedEmphysemaUnited States
-
Mylan Inc.Theravance BiopharmaCompletedChronic Obstructive Pulmonary Disease, COPDNew Zealand
-
Dicerna Pharmaceuticals, Inc., a Novo Nordisk companyCompleted
-
Mylan Inc.Theravance BiopharmaCompleted
-
Middlemore Hospital, New ZealandUnknownPulmonary Parenchymal LesionsNew Zealand
-
Waikato HospitalWaikato Hospital Research FundCompletedChronic Obstructive Pulmonary DiseaseNew Zealand
-
Weill Medical College of Cornell UniversityNational Heart, Lung, and Blood Institute (NHLBI)CompletedSmoking | Emphysema | HIV | COPDUnited States
-
Institut für Pneumologie Hagen Ambrock eVPneumRx, Inc.CompletedEmphysema | COPDGermany
-
Weill Medical College of Cornell UniversityCompletedSmoking | Smoking Cessation | Emphysema | Chronic Obstructive Pulmonary Disease (COPD) | Chronic BronchitisUnited States
-
University of Auckland, New ZealandTerminatedSmoking Cessation | Chronic Obstructive Pulmonary DiseaseNew Zealand
-
Boston Scientific CorporationPneumRx, Inc.TerminatedEmphysemaUnited States, Netherlands, France, Canada, United Kingdom
-
JHSPH Center for Clinical TrialsUniversity of PittsburghCompleted
-
Boston Scientific CorporationPneumRx, Inc.TerminatedEmphysemaUnited States, Netherlands, France, Canada, Germany, United Kingdom
-
SunovionCompletedChronic Obstructive Pulmonary Disease | Emphysema | BronchitisUnited States
-
Inhibrx, Inc.RecruitingEmphysema | Alpha 1-Antitrypsin DeficiencyUnited States, Australia, United Kingdom, New Zealand
-
Spiration, Inc.CompletedEmphysemaUnited States, Canada
-
Spiration, Inc.Completed
-
Aeris TherapeuticsTerminatedPulmonary EmphysemaUnited States, Spain, France, Israel, Netherlands, Greece, Italy
-
InSilico Medicine Hong Kong LimitedCompletedA Phase 1, Evaluate the Safety, Tolerability, and Pharmacokinetics of INS018_055 in Healthy SubjectsIdiopathic Pulmonary FibrosisNew Zealand
-
United TherapeuticsCompletedPulmonary Hypertension | Interstitial Lung Disease | Combined Pulmonary Fibrosis and EmphysemaUnited States, Puerto Rico
-
Brigham and Women's HospitalNational Heart, Lung, and Blood Institute (NHLBI)Active, not recruitingExamining the Genetic Factors That May Cause Chronic Obstructive Pulmonary Disease (COPD) (COPDGene)Pulmonary Disease, Chronic Obstructive | Emphysema | Bronchitis, ChronicUnited States
-
University of OtagoHealth Research Council, New ZealandCompleted
-
United TherapeuticsTerminatedPulmonary Hypertension | Interstitial Lung Disease | Combined Pulmonary Fibrosis and EmphysemaUnited States, Puerto Rico
-
Fisher and Paykel HealthcareMedical Research Institute of New Zealand; Alana HealthcareTerminatedChronic Obstructive Pulmonary Disease | COPDUnited States, New Zealand
-
Broncus TechnologiesUnknownEmphysemaUnited States, Spain, Australia, Canada, Ireland, United Kingdom, Austria, Brazil, Germany, Netherlands
-
US Department of Veterans AffairsTerminatedEmphysema | COPDUnited States
-
SunovionCompletedChronic Obstructive Pulmonary Disease | Emphysema | BronchitisUnited States
-
Gerard TurinoCompletedEmphysema | Alpha 1-Antitrypsin DeficiencyUnited States, Canada
-
Columbia UniversityAlpha-1 FoundationRecruitingChronic Obstructive Pulmonary Disease | Acute Exacerbation Copd | Alpha-1 Anti-trypsin DeficiencyUnited States
-
Baxalta now part of ShireCompletedAlpha 1-Antitrypsin DeficiencyNew Zealand, Australia
-
CSL BehringCompletedEmphysema | Alpha1-proteinase Inhibitor DeficiencyAustralia, Russian Federation, United States, Denmark, Estonia, Finland, Germany, Ireland, Poland, Romania, Sweden, Canada, Czech Republic
-
GlaxoSmithKlineCompleted
-
Baxalta now part of ShireBaxter Healthcare, Ltd. (New Zealand), Baxter Healthcare Pty. Ltd. (Australia)CompletedAlpha 1-Antitrypsin DeficiencyAustralia, New Zealand
-
VenitiWithdrawnDeep Vein Thrombosis | Pulmonary EmbolusNew Zealand, Australia
-
Pearl Therapeutics, Inc.CompletedChronic Obstructive Pulmonary DiseaseAustralia, New Zealand
-
CSL BehringCompletedEmphysema | Alpha 1-proteinase Inhibitor DeficiencyAustralia, Canada, Czech Republic, Denmark, Estonia, Finland, Germany, Ireland, Poland, Romania, Sweden
-
Alpha-1 FoundationCompletedChronic Obstructive Pulmonary Disease | Alpha-1 Antitrypsin DeficiencyUnited States, Puerto Rico
-
Weill Medical College of Cornell UniversityNational Heart, Lung, and Blood Institute (NHLBI); University of California... and other collaboratorsRecruitingEmphysema | HIVUnited States
-
Arrowhead PharmaceuticalsRecruitingIdiopathic Pulmonary FibrosisDenmark, New Zealand, Spain
-
Baxalta now part of ShireBaxalta Innovations GmbH, now part of ShireTerminatedChronic Obstructive Pulmonary Disease | Alpha1-antitrypsin DeficiencyUnited States, Canada, Australia